Pricing Log in Create free account

Lite Strategy, Inc. (LITS) vs Polyrizon Ltd. (PLRZ)

Lite Strategy, Inc. and Polyrizon Ltd. are both Biotechnology companies. Lite Strategy, Inc. and Polyrizon Ltd. are of similar size ($29.6M and $27.5M). Across the 7 metrics below, Polyrizon Ltd. leads on 6 and Lite Strategy, Inc. on 1.

Valuation

Metric LITS PLRZ Biotechnology median
P/E n/m — 10.60
P/S 0.33 — 9.40
P/B 0.84 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.28 n/m 9.02
Earnings yield (196.04%) — (32.88%)
Free cash flow yield (298.16%) 0.00% (23.13%)

Profitability

Metric LITS PLRZ Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (243.02%) 0.00% (51.96%)
Return on assets (233.37%) 0.00% (46.06%)
Return on invested capital (115.85%) 0.00% 0.00%

Growth

Metric LITS PLRZ Biotechnology median
Revenue growth (TTM) 152.90% — 6.76%
EPS growth (last fiscal year) 13.81% 99.39% 29.88%
Revenue growth, 5-year CAGR 67.75% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LITS PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.74 36.37 4.97
Net debt to EBITDA 0.09 2.11 1.01

Dividend

Metric LITS PLRZ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LITS PLRZ Biotechnology median
Market cap 29.56m 27.49m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack